Longevity.Technology (@LongevityTech)· LongevityTech·· 1 天前评分8
牛津生物科技获4700万美元扩产mRNA
Oxford biotech secures $47 million to scale cell-based mRNA manufacturing, with an eye on therapies that require repeated dosing.
导读
牛津生物科技获4700万美元，用于扩大基于细胞的mRNA生产规模，并着眼于需要重复给药的疗法。 https://vist.ly/5n6wp #longevity #biotech #mRNA #manufacturing #therapies
来源：Longevity.Technology (@LongevityTech) · x.com